Terms: = Uterine cancer AND LIFR, SJS2, 3977, ENSG00000113594, SWS, STWS, CD118 AND Treatment
3 results:
1. The lifr Inhibitor EC359 Effectively Targets Type II Endometrial cancer by Blocking LIF/lifr Oncogenic Signaling.
Spencer N; Rodriguez Sanchez AL; Gopalam R; Subbarayalu P; Medina DM; Yang X; Ramirez P; Randolph L; Aller EJ; Santhamma B; Rao MK; Tekmal RR; Nair HB; Kost ER; Vadlamudi RK; Viswanadhapalli S
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139260
[TBL] [Abstract] [Full Text] [Related]
2. How noninvasive treatment of uterine fibroids affects endometrial receptivity: a prospective cohort study.
Melkozerova O; Shchedrina I; Gryshkina A; Bashmakova N; Malgina G; Michelson A; Chistyakova G
Gynecol Endocrinol; 2020; 36(sup1):28-32. PubMed ID: 33305668
[TBL] [Abstract] [Full Text] [Related]
3. heterogeneity of dna ploidy in endometrial carcinoma: comparison of different tissue samples obtained during diagnosis and treatment.
Libalova P; Vernerova Z; Hubickova-Heringova L; Pinterova D; Kolostova K; Bobek V; Tikovsky K; Housa D; Kubecova M; Pecen L; Svoboda B
In Vivo; 2012; 26(3):473-80. PubMed ID: 22523302
[TBL] [Abstract] [Full Text] [Related]
